FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014077191> ?p ?o ?g. }

• W2014077191 endingPage "33" @default.
• W2014077191 startingPage "27" @default.
• W2014077191 abstract "Clinicians had suspected for years that drug eruptions were probably mediated by immune mechanisms because their timing suggested sensitization and specific immunologic memory rather than direct toxicity. An immune response to medications was also demonstrated by positive skin tests and by several types of in vitro tests that evidenced immediate or delayed hypersensitivity. In the last decade several teams of researchers obtained in vitro drug-specific human T-cell clones, in a variety of clinical types of drug eruptions. These clones were produced from blood or skin mononuclear cells of patients with a history of drug reaction by stimulation in vitro with drug. They were either of CD4 or CD8 phenotypes. Drug specific clones were stimulated by the parent drug much more often than by reactive metabolites. That challenged the classical “hapten hypothesis” that the immune response was initiated by reactive metabolites combined to self proteins. The medication usually stimulated specific T-cells after non-covalent binding to major histocompatibility(MHC)molecules on antigen presenting cells. In toxic epidermal necrolysis, T-lymphocytes present at the site of lesions, exhibited a drug specific cytotoxicity against autologous target cells, or allogeneic cells that shared the same HLA than autologous cells. This MHC class I restriction and mediation of death by perforin/granzyme release, is the classical behavior of cytotoxic T lymphocytes, like those operating in the reject of a transplanted organ. MHC restriction could explain the key role of HLA genes as predisposing factors to severe drug reactions. A strong association between HLA and hypersensitivity to abacavir, SJS or TEN to carbamazepine or allopurinol has been recently demonstrated. Resemblance to graft rejection points to the possible therapeution value of immuno suppressive agents. Most drug eruptions appear to result from T-cell mediated delayed hypersensitivity. The secondary activation of different cascades of cytokines, may contribute to the heterogeneity of clinical presentations." @default.
• W2014077191 created "2016-06-24" @default.
• W2014077191 creator A5004423617 @default.
• W2014077191 date "2006-01-01" @default.
• W2014077191 modified "2023-10-16" @default.
• W2014077191 title "Immune Mechanisms in Drug Allergy" @default.
• W2014077191 cites W1516728281 @default.
• W2014077191 cites W1964975531 @default.
• W2014077191 cites W1969575821 @default.
• W2014077191 cites W1969879564 @default.
• W2014077191 cites W1986140195 @default.
• W2014077191 cites W1994622429 @default.
• W2014077191 cites W1995906553 @default.
• W2014077191 cites W1995968109 @default.
• W2014077191 cites W1999369567 @default.
• W2014077191 cites W2000386027 @default.
• W2014077191 cites W2014048895 @default.
• W2014077191 cites W2021384711 @default.
• W2014077191 cites W2025805650 @default.
• W2014077191 cites W2035351158 @default.
• W2014077191 cites W2037914591 @default.
• W2014077191 cites W2043951720 @default.
• W2014077191 cites W2044317927 @default.
• W2014077191 cites W2044827382 @default.
• W2014077191 cites W2049902892 @default.
• W2014077191 cites W2049942972 @default.
• W2014077191 cites W2052110525 @default.
• W2014077191 cites W2058391540 @default.
• W2014077191 cites W2064429284 @default.
• W2014077191 cites W2068902509 @default.
• W2014077191 cites W2076514222 @default.
• W2014077191 cites W2077025580 @default.
• W2014077191 cites W2079780398 @default.
• W2014077191 cites W2080789152 @default.
• W2014077191 cites W2083508836 @default.
• W2014077191 cites W2087094124 @default.
• W2014077191 cites W2089378839 @default.
• W2014077191 cites W2089708688 @default.
• W2014077191 cites W2094778297 @default.
• W2014077191 cites W2120113940 @default.
• W2014077191 cites W2123319103 @default.
• W2014077191 cites W2130634763 @default.
• W2014077191 cites W2136859392 @default.
• W2014077191 cites W2140055542 @default.
• W2014077191 cites W2141430027 @default.
• W2014077191 cites W2152226036 @default.
• W2014077191 cites W2164740372 @default.
• W2014077191 cites W2317624504 @default.
• W2014077191 cites W2321102680 @default.
• W2014077191 cites W4233325314 @default.
• W2014077191 cites W4300713168 @default.
• W2014077191 cites W4321508824 @default.
• W2014077191 doi "https://doi.org/10.2332/allergolint.55.27" @default.
• W2014077191 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17075283" @default.
• W2014077191 hasPublicationYear "2006" @default.
• W2014077191 type Work @default.
• W2014077191 sameAs 2014077191 @default.
• W2014077191 citedByCount "94" @default.
• W2014077191 countsByYear W20140771912012 @default.
• W2014077191 countsByYear W20140771912013 @default.
• W2014077191 countsByYear W20140771912014 @default.
• W2014077191 countsByYear W20140771912015 @default.
• W2014077191 countsByYear W20140771912016 @default.
• W2014077191 countsByYear W20140771912017 @default.
• W2014077191 countsByYear W20140771912018 @default.
• W2014077191 countsByYear W20140771912019 @default.
• W2014077191 countsByYear W20140771912020 @default.
• W2014077191 countsByYear W20140771912021 @default.
• W2014077191 countsByYear W20140771912022 @default.
• W2014077191 countsByYear W20140771912023 @default.
• W2014077191 crossrefType "journal-article" @default.
• W2014077191 hasAuthorship W2014077191A5004423617 @default.
• W2014077191 hasBestOaLocation W20140771911 @default.
• W2014077191 hasConcept C147483822 @default.
• W2014077191 hasConcept C154317977 @default.
• W2014077191 hasConcept C167672396 @default.
• W2014077191 hasConcept C188280979 @default.
• W2014077191 hasConcept C202751555 @default.
• W2014077191 hasConcept C203014093 @default.
• W2014077191 hasConcept C207480886 @default.
• W2014077191 hasConcept C207936829 @default.
• W2014077191 hasConcept C2779060952 @default.
• W2014077191 hasConcept C2780664588 @default.
• W2014077191 hasConcept C54355233 @default.
• W2014077191 hasConcept C55493867 @default.
• W2014077191 hasConcept C71924100 @default.
• W2014077191 hasConcept C86803240 @default.
• W2014077191 hasConcept C8891405 @default.
• W2014077191 hasConceptScore W2014077191C147483822 @default.
• W2014077191 hasConceptScore W2014077191C154317977 @default.
• W2014077191 hasConceptScore W2014077191C167672396 @default.
• W2014077191 hasConceptScore W2014077191C188280979 @default.
• W2014077191 hasConceptScore W2014077191C202751555 @default.
• W2014077191 hasConceptScore W2014077191C203014093 @default.
• W2014077191 hasConceptScore W2014077191C207480886 @default.
• W2014077191 hasConceptScore W2014077191C207936829 @default.
• W2014077191 hasConceptScore W2014077191C2779060952 @default.
• W2014077191 hasConceptScore W2014077191C2780664588 @default.

• next